EQUR — E-Qure Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $0.16m
Annual income statement for E-Qure, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | C2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.974 | 0.846 | 2 | 0.43 | 0.648 |
| Operating Profit | -0.974 | -0.846 | -2 | -0.43 | -0.648 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.974 | -0.853 | -2.01 | -0.437 | -0.612 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.974 | -0.853 | -2.01 | -0.437 | -0.612 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.974 | -0.853 | -2.01 | -0.437 | -0.612 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.974 | -0.853 | -2.01 | -0.437 | -0.612 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.057 | -0.038 | -0.064 | -0.013 | -0.018 |
| Dividends per Share |